Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo‐Controlled Studies in Healthy Vol...

Por Erpenbeck, Veit J., Vets, Eva, Gheyle, Lien, Osuntokun, Wande, Larbig, Michael, Neelakantham, Srikanth, Sandham, David, Dubois, Gerald, Elbast, Walid, Goldsmith, Paul, Weiss, Markus
Publicado no Clin Pharmacol Drug Dev (2016)

A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone

Por Simen, Arthur A., Gargano, Cynthia, Cha, Jang-Ho, Drexel, Melissa, Bautmans, An, Heirman, Ingeborg, Laethem, Tine, Hochadel, Thomas, Gheyle, Lien, Bleys, Kim, Beals, Chan, Stoch, Aubrey, Kay, Gary G., Struyk, Arie
Publicado no Ther Adv Drug Saf (2015)